MedPath

Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program

Not Applicable
Recruiting
Conditions
Breast Cancer
Interventions
Behavioral: Nutrition and physical activity counseling program
Registration Number
NCT04365569
Lead Sponsor
Case Comprehensive Cancer Center
Brief Summary

More than 65% of breast cancer survivors are overweight and less than one-third participate in recommended levels of physical exercise. Obese breast cancer survivors have been found to have greater than a two-fold increase in mortality compared to women with normal body mass index (BMI). The current standard for weight loss interventions involves in-person counseling. However, this incurs costs related to travel for counseling sessions, potentially limiting program participation, compliance and sustainability.This is a pilot study of an individualized in-person and telephone-based nutrition and exercise counseling program.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Breast cancer diagnosis (stage 0-III)
  • Body mass index of 25mg/k2 or greater
  • Actively being followed by medical oncologist, radiation oncologist, and/or breast surgeon at Maroone Cancer Center
  • Able and willing to participate in nutrition counseling at Maroone Cancer Center
  • Able (cleared by participant's primary oncologist) and willing to perform cardiopulmonary exercise testing
  • Participants must have the ability to understand and the willingness to sign a written informed consent document
  • Performance status 0 or 1 as per ECOG scale [see Appendix IV]
Exclusion Criteria
  • Body mass index below 25kg/m2
  • No prior history of breast cancer
  • History of metastatic disease
  • Not being followed by medical oncologist, radiation oncologist, and/or breast surgeon at Maroone Cancer Center
  • Unable or unwilling to participate in nutrition counseling at Maroone Cancer Center
  • Participants with uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
  • Participants actively undergoing chemotherapy, immunotherapy or radiation treatment. However, participants currently taking hormonal therapy, such as selective estrogen receptor modulators (SERMS), or aromatase inhibitors, may be included in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Individualized, nutrition and physical activity interventionNutrition and physical activity counseling programInitial in-person consult with a registered dietitian, with further in-person follow-ups and monthly telephone consults
Primary Outcome Measures
NameTimeMethod
Percent of participants achieving 10% weight lossAt 6 months

Efficacy of intervention as assessed by percent of participants achieving 10% weight loss

Compliance to physical activity goalAt 6 months

Percent of participants complying with proposed activity goal of 150 minutes of moderate intensity physical activity or 75 minutes of vigerous intensity physical activity (or a combination of both) per week over six months

Compliance to the recommended dietary patternAt 3 months

Assess compliance to the recommended dietary pattern, diet quality scores will be calculated by the RD after monthly telephone consults or in-person at 3 months and 6 months into the intervention. Each of the 3 elements will be scored from 0-3, resulting in a total score range from 0-9

Secondary Outcome Measures
NameTimeMethod
Maximum oxygen uptake as measured by VO2 maxAt 6 months

Maximum oxygen uptake as measured by VO2 max

Glycemic control as measured by HbA1cAt 6 months

Glycemic control as measured by HbA1c

high density lipoproteinAt 6 months

Effect of the intervention on lipid profile as measured by high density lipoprotein levels

Serum C-reactive protein (CRP)At 6 months

Effect of the intervention on CRP

CholesterolAt 6 months

Effect of the intervention on lipid profile as measured by high density cholesterol levels

Low density lipoproteinAt 6 months

Effect of the intervention on lipid profile as measured by low density lipoprotein levels

TriglyceridesAt 6 months

Effect of the intervention on lipid profile as measured by triglyceride levels

Serum vitamin DAt 6 months

Effect of the intervention on serum vitamin D

Body fat percentage6 months

Body fat percentage measured by the registered dietitian (RD) using bioelectrical impedance analysis

Trial Locations

Locations (1)

Cleveland Clinic Florida Weston, Case Comprehensive Cancer Center

🇺🇸

Weston, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath